Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Edge, SCPMG to Evaluate Bladder Cancer Dx

NEW YORK (GenomeWeb) – Pacific Edge announced on Wednesday an agreement with the Southern California Permanente Medical Group for the evaluation of Pacific Edge's gene expression-based test for the detection of bladder cancer.

About 2,000 patients presenting with microscopic and macroscopic hematuria will be recruited as part of the Kaiser Permanente User Program research project, which is expected to begin later this year.

Urine samples will be collected and sent to Pacific Edge Diagnostic USA, the company's CLIA-registered laboratory in Hershey, Pa., for analysis with Pacific Edge's test called Cxbladder. Results will be collated with clinical information and analyzed independently by SCPMG, with final results of the program to be completed in early 2015, Pacific Edge said.

Cxbladder measures the gene expression levels of five biomarkers that represent a bladder cancer signature in order to help rule out cancer in patients. The test is also being evaluated in New Zealand, where the company is headquartered, in a clinical program by Mid-Central District Health Board in Palmerston North to establish the levels of patient benefits and savings that may be achieved using the test.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.